284 related articles for article (PubMed ID: 35059992)
21. Among sinonasal tumors, CDX-2 immunoexpression is not restricted to intestinal-type adenocarcinomas.
Tilson MP; Gallia GL; Bishop JA
Head Neck Pathol; 2014 Mar; 8(1):59-65. PubMed ID: 23846317
[TBL] [Abstract][Full Text] [Related]
22. Sox2 and βIII-Tubulin as Biomarkers of Drug Resistance in Poorly Differentiated Sinonasal Carcinomas.
López L; Fernández-Vañes L; Cabal VN; García-Marín R; Suárez-Fernández L; Codina-Martínez H; Lorenzo-Guerra SL; Vivanco B; Blanco-Lorenzo V; Llorente JL; López F; Hermsen MA
J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888115
[TBL] [Abstract][Full Text] [Related]
23. SMARCB1 (INI-1)-Deficient Adenocarcinoma of the Sinonasal Tract: A Potentially Under-Recognized form of Sinonasal Adenocarcinoma with Occasional Yolk Sac Tumor-Like Features.
Shah AA; Jain D; Ababneh E; Agaimy A; Hoschar AP; Griffith CC; Magliocca KR; Wenig BM; Rooper LM; Bishop JA
Head Neck Pathol; 2020 Jun; 14(2):465-472. PubMed ID: 31468350
[TBL] [Abstract][Full Text] [Related]
24. Clinical management of emerging sinonasal malignancies.
Contrera KJ; Woody NM; Rahman M; Sindwani R; Burkey BB
Head Neck; 2020 Aug; 42(8):2202-2212. PubMed ID: 32212360
[TBL] [Abstract][Full Text] [Related]
25. INI-1 (SMARCB1)-Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal Malignancies.
Shaverdashvili K; Azimi-Nekoo E; Cohen P; Akbar N; Ow TJ; Halmos B; Castellucci E
Oncologist; 2020 Sep; 25(9):738-744. PubMed ID: 32337786
[TBL] [Abstract][Full Text] [Related]
26. The importance of multimodality therapy in the treatment of sinonasal neuroendocrine carcinoma.
van der Laan TP; Bij HP; van Hemel BM; Plaat BE; Wedman J; van der Laan BF; Halmos GB
Eur Arch Otorhinolaryngol; 2013 Sep; 270(9):2565-8. PubMed ID: 23740425
[TBL] [Abstract][Full Text] [Related]
27. Relationship between
Felix-Ravelo M; Bey A; Arous F; Paris-Grandpierre S; Jankowski R; Nguyen DT
Acta Otolaryngol; 2017 Feb; 137(2):191-195. PubMed ID: 27576899
[TBL] [Abstract][Full Text] [Related]
28. Molecularly defined sinonasal malignancies: an overview with focus on the current WHO classification and recently described provisional entities.
Skálová A; Agaimy A; Bradova M; Poorten VV; Hanna E; Guntinas-Lichius O; Franchi A; Hellquist H; Simpson RHW; Lopéz F; Nuyts S; Chiesa-Estomba C; Ng SP; Homma A; Teng Y; Leivo I; Ferlito A
Virchows Arch; 2024 Jun; 484(6):885-900. PubMed ID: 38491228
[TBL] [Abstract][Full Text] [Related]
29. Sinonasal tumor pathology: what's new?
Franchi A
Pathologica; 2017 Mar; 109(1):9-13. PubMed ID: 28635989
[TBL] [Abstract][Full Text] [Related]
30. Misdiagnosis of olfactory neuroblastoma.
Cohen ZR; Marmor E; Fuller GN; DeMonte F
Neurosurg Focus; 2002 May; 12(5):e3. PubMed ID: 16119901
[TBL] [Abstract][Full Text] [Related]
31. Molecular profiling of sinonasal undifferentiated carcinoma.
Gelbard A; Hale KS; Takahashi Y; Davies M; Kupferman ME; El-Naggar AK; Myers JN; Hanna EY
Head Neck; 2014 Jan; 36(1):15-21. PubMed ID: 23633104
[TBL] [Abstract][Full Text] [Related]
32. Sinonasal undifferentiated carcinoma: a distinctive clinicopathologic entity.
Houston GD; Gillies E
Adv Anat Pathol; 1999 Nov; 6(6):317-23. PubMed ID: 10562893
[TBL] [Abstract][Full Text] [Related]
33. Sinonasal undifferentiated carcinoma: an update.
Enepekides DJ
Curr Opin Otolaryngol Head Neck Surg; 2005 Aug; 13(4):222-5. PubMed ID: 16012246
[TBL] [Abstract][Full Text] [Related]
34. Major driver mutations are shared between sinonasal intestinal-type adenocarcinoma and the morphologically identical colorectal adenocarcinoma.
Sjöstedt S; Schmidt AY; Vieira FG; Willemoe GL; Agander TK; Olsen C; Nielsen FC; von Buchwald C
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1019-1027. PubMed ID: 33051725
[TBL] [Abstract][Full Text] [Related]
35. A clinicopathological study of sinonasal neuroendocrine carcinoma and sinonasal undifferentiated carcinoma.
Smith SR; Som P; Fahmy A; Lawson W; Sacks S; Brandwein M
Laryngoscope; 2000 Oct; 110(10 Pt 1):1617-22. PubMed ID: 11037813
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical distinction of intestinal-type sinonasal adenocarcinoma from metastatic adenocarcinoma of intestinal origin.
Resto VA; Krane JF; Faquin WC; Lin DT
Ann Otol Rhinol Laryngol; 2006 Jan; 115(1):59-64. PubMed ID: 16466101
[TBL] [Abstract][Full Text] [Related]
37. INI1 (SMARCB1)-Deficient Sinonasal Carcinoma: A Clinicopathologic Report of 2 Cases.
Wasserman JK; Dickson BC; Perez-Ordonez B; de Almeida JR; Irish JC; Weinreb I
Head Neck Pathol; 2017 Jun; 11(2):256-261. PubMed ID: 27644951
[TBL] [Abstract][Full Text] [Related]
38. [Undifferentiated malignant round cell tumors of the sinonasal tract and nasopharynx].
Casiraghi O; Lefèvre M
Ann Pathol; 2009 Sep; 29(4):296-312. PubMed ID: 19900635
[TBL] [Abstract][Full Text] [Related]
39. Sinonasal carcinomas: recent advances in molecular and phenotypic characterization and their clinical implications.
Franchi A; Miligi L; Palomba A; Giovannetti L; Santucci M
Crit Rev Oncol Hematol; 2011 Sep; 79(3):265-77. PubMed ID: 20870420
[TBL] [Abstract][Full Text] [Related]
40. Primary sinonasal mucosal melanoma with aberrant diffuse and strong desmin reactivity: a potential diagnostic pitfall!
Smith SM; Schmitt AC; Carrau RL; Iwenofu OH
Head Neck Pathol; 2015 Mar; 9(1):165-71. PubMed ID: 24974197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
